Forty-four U.S. states have joined together in a lawsuit against 20 drug manufacturers, accusing them of scheme to inflate drug prices and eliminate competition in the market, Reuters reported. The drugmakers are accused of jacking up the prices by more than 1,000% in some cases.

As the Trump administration looks for ways to reduce the burden on Americans when they receive a surprise medical bill, it could borrow ideas from New York, which approved legislation in 2014 that has safeguarded residents in the state from being hit with out-of-network charges.

With high compensation and a good work-life balance, Minnesota is the best state for physicians to thrive in 2019, according to a recent ranking from Medscape.

CVS Health is still embroiled in a dispute over its $69 billion merger with Aetna, which was approved by the Department of Justice last year and closed in late 2018. However, U.S. District Judge Richard Leon isn’t so sure the deal hasn’t crossed any antitrust laws and is reviewing the case in court.

Private health insurance plans, which cover the majority of people in the U.S., paid higher rates to hospitals compared to public plans such as Medicare and Medicaid, according to a recent report from RAND.


Fewer hospital CEOs are leaving their jobs, according to a report from Challenger, Gray & Christmas on CEO turnover. During the first four months of 2019, 26 hospital CEOs left their jobs, compared to 35 departures during the same time period in 2018.

President Trump announced principles to address the issue of surprise billing in healthcare, the White House announced May 9.

The savings that Medicare Advantage plans can bring to the table may have been over-weighted after a recent study revealed seniors who switch from traditional Medicare plans already have lower healthcare costs before they join an MA plan.

The FDA is putting an end to a program that allowed medical device companies to keep the public in the dark about reports of harm and malfunction. The program, called alternative summary reporting, was established in 1997 and its data has not been publicly available.

Adopting the prices of other countries could potentially have helped save Medicare part D as much as $72.8 billion in 2018, as drug prices in the U.S. averaged 3.2 to 4.1 times higher after rebates compared to the U.K., Japan and Ontario, Canada, according to a study published in Health Affairs.

HHS has finalized a rule that will require drug companies to publish the list prices of drugs in television ads. 

CMS is taking steps to streamline the review process for states that apply for section 1915 waivers and state plan amendments, CMS Administrator Seema Verma announced May 7.